fashion -WSS

fashion

author：explore 2025-10-01 10:56:51 - browse：72

Robert F. Kennedy Jr. said Tuesday that he will head up a panel on vaccine safety for Donald Trump.

The president-elect’s transition team spokeswoman later walked that back, saying that he is “exploring the possibility” of forming a panel on autism, but “no decisions have been made.”

Let’s hope Trump drops any idea of a vaccine panel headed by Kennedy. For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality. If Kennedy’s panel leads to even a small decline in vaccine rates across the country, it will result in the waste of untold amounts of money and, in all likelihood, the preventable deaths of infants too young to be vaccinated.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Complete sequence of Y chromosome published for first time

knowledge

WSS

Chris Christie meets with Zelenskyy during Ukraine trip

What do new weight loss drugs mean for bariatric surgery?

2024 GOP presidential candidates spar over abortion in debate

Apellis safety probe of eye disease drug centers on injection needle

NYU Langone launches private ChatGPT for its health care data

It costs an awful lot of money to give away a kidney

focus

fashion

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Australia’s approach to dialysis celebrates life

Medicare proposal to cover medical devices draws a mixed reaction

Chris Christie meets with Zelenskyy during Ukraine trip

Dobbs anniversary: the lost opportunity of abortion as health care

CDC advisory panel says seniors 'may' get RSV vaccine

Peter Hotez and the public health issue of online harassment

Late stage cancers on the rise after pandemic delayed screenings

Affirmative action in medical school literally saved lives

Complete sequence of Y chromosome published for first time

hotspot

Late stage cancers on the rise after pandemic delayed screenings

Why more medical students aren't specializing in primary care

Biotech startup Celsius cuts 75% of staff ahead of first trial start

When waiting feels immoral: Empathy in the emergency department

AstraZeneca challenges Medicare drug negotiation program

Group behind ProMed defends move to subscription

Wikipedia

explore

knowledge

explore